Get started
Author

Taylor Pasley

Observed name: T. Pasley
Institution: Houston Methodist
ORCID: 0000-0002-7536-3899
Observed ORCID: 0000-0002-7536-3899
OpenAlex ID: A5002833162
Immune outcomes of lung transplant recipients with different cytochrome P450 3A5 phenotypes after discontinuation of voriconazole antifungal prophylaxis
2024 · Zoe H. Tu, Brett J. Pierce, et al. · Clinical Transplantation · 3
Development of Maribavir-Resistant Cytomegalovirus Infection Following Treatment of Ganciclovir-Resistant Cytomegalovirus Infection
2024 · A. Hutchins, T. Pasley · The Journal of Heart and Lung Transplantation · 2
PDF
A Donor Derived Cell Free DNA Approach to Immunosuppression Minimization in Elderly Kidney Transplant Recipients
2025 · A.W. Rogers, A. Yun, et al. · American Journal of Transplantation · 1
PDF
Bridging Echinocandin With Azole Antifungal Therapy on Prevention of Invasive Candidiasis Post–Lung Transplantation
2024 · Taylor Pasley, Christopher Baladad, et al. · Open Forum Infectious Diseases · 1
PDF
The Ventilatory Equivalent for Carbon Dioxide Slope Independently Predicts Perioperative Outcomes in Patients Undergoing Heart Transplantation
2022 · D. Jayasimhan, R. Welch, et al. · The Journal of Heart and Lung Transplantation · 1
PDF
Less is More? Low-Dose Valganciclovir in Pancreas Transplantation
2025 · T. Pasley, A.W. Rogers, et al. · American Journal of Transplantation
Lymphocytic Redemption: Letermovir Conversion for Primary CMV Prophylaxis in Thoracic versus Abdominal Transplant
2025 · S. Amin, A. Yun, et al. · American Journal of Transplantation
Works count: 7
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type